The practical steps serialization, compliance and supply chain teams should take in 2026–2027.
The FDA’s final rule on the 12-digit NDC transition has shifted the conversation from awareness to preparation.
While the compliance deadline is set for 2033, pharmaceutical companies that wait until the end of the decade to start planning may face unnecessary costs, resource constraints, and implementation risks. The organizations that will be best positioned for a successful transition are those using 2026 and 2027 to conduct a structured NDC impact assessment and build a realistic implementation roadmap.
Although March 7, 2033 is the effective date of the final rule, the labeling transition will continue for a further three years, through March 6, 2036. During this period, the continued use of 10-digit NDCs on product labeling will be tolerated, with regulatory action related to non-compliant labeling becoming possible only after the transition period has ended.
Start with an NDC impact assessment
Identify every system, interface, process and report that relies on NDC data, including serialization systems, ERP platforms, product master data, labeling systems, regulatory databases, data warehouses, partner integrations and reporting tools.
Identify hidden technical risks
Review fixed field lengths, parsing logic, validation rules, custom integrations, data transformation processes and reporting mechanisms that may rely on current NDC structures.
Review GTIN and serialization dependencies
Assess NDC-to-GTIN relationships, product hierarchy management, serialization master data, packaging configurations and partner data exchanges.
Engage trading partners early
Begin readiness discussions with CMOs, wholesalers, solution providers and distributors to align timelines, testing responsibilities and implementation approaches.
Build an NDC validation strategy
Identify impacted validated systems, estimate regression testing effort, review CSV documentation and define validation ownership.
Establish cross-functional governance
Create a governance model involving Regulatory Affairs, Supply Chain, Serialization, Quality, IT, Packaging Operations and Master Data Management.
Develop a multi-year NDC readiness roadmap
Build a roadmap covering impact assessment, system readiness reviews, partner readiness, validation planning, testing preparation, labeling updates and business continuity planning.
How Nubinno supports the 12-Digit NDC transition
The organizations that will manage the NDC transition most successfully are not necessarily those with the largest budgets, but those that start preparing early and make informed decisions.
Nubinno supports pharmaceutical companies in assessing readiness, prioritizing actions, and building realistic transition plans based on operational, technical, and compliance considerations.
